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Abstract
Background—Prevention of unplanned pregnancies is a critical element in the prevention of 
mother-to-child transmission of HIV infection, but its potential has not been fully realized. We 
assessed the utilization of family planning (FP) and fertility desires among women of reproductive 
age by HIV status.
Methods—We selected a nationally representative sample of households using a stratified 2-
stage cluster design and surveyed women aged 15–49 years. We administered questionnaires and 
examined predictors of current use of FP and desire for children among sexually active women 
with known HIV infection and women who were HIV uninfected.
Results—Of 3583 respondents, 68.2% were currently using FP, and 57.7% did not desire 
children in the future. Among women who did not desire children in the future, 70.9% reported 
that they were using FP, including 68.7% of women with known HIV infection and 71.0% of 
women who were HIV uninfected. Women with known HIV infection had similar odds of using 
FP as women with no HIV infection (odds ratio, 1.12; 95% confidence interval: 0.81 to 1.54). 
Women with no HIV infection had significantly higher adjusted odds of desiring future children 
(adjusted OR, 2.27; 95% confidence interval: 1.31 to 3.93) than women with known HIV 
infection.
Conclusions—There is unmet need for FP for HIV-infected women, underscoring a gap in the 
national prevention of mother-to-child transmission of HIV strategy. Efforts to empower HIV-
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infected women to prevent unintended pregnancies should lead to expanded access to 
contraceptive methods and take into account women’s reproductive intentions.
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INTRODUCTION
Women of childbearing age account for nearly half of all persons infected with HIV 
worldwide,1 and without interventions to prevent mother-to-child transmission of HIV, 
12%–40% of HIV-infected pregnant women will transmit HIV to their infants.2 More than 
1.4 million Kenyans were estimated to be living with HIV infection, and HIV prevalence 
was estimated to be 9.2% among women of reproductive age in the first Kenya AIDS 
Indicator Survey conducted in 2007 (KAIS 2007).3 The high prevalence of HIV among 
women of reproductive age raises concerns regarding the capacity of programs for the 
prevention of mother-to-child transmission of HIV (PMTCT) to care for infected women 
and their exposed newborns.
Prevention of unintended pregnancy is the second prong of the Joint United Nations 
Programme on HIV/AIDS PMTCT program framework,4 but uptake of contraceptives is 
generally low in Kenya. According to the 2008–2009 Kenya Demographic and Health 
Survey (DHS), 32% of women aged 15–49 years used any contraceptive method despite 
high level of knowledge of family planning (FP).5 KAIS 2007 found low levels (45%) of 
modern contraceptive use among Kenyan women aged 15–49 years who did not desire a 
child in the future.3 The low uptake of FP among the general population in Kenya presents a 
risk to the success of PMTCT interventions in the country. Studies have shown there is 
similarly low utilization of FP methods among HIV-infected women elsewhere in East 
Africa. Among HIV-infected mothers in the PMTCT program in Kitale District Hospital in 
western Kenya, only 44% had been using some form of FP.6 Similarly, a study in Uganda 
reported that slightly more than half (51.6%) of HIV-infected women were using a FP 
method at the time of the study.7
DHS data from Kenya and Malawi show that nearly three-fourths of HIV-infected women 
did not want to have more children in the future, but only 20% of these women in Kenya and 
32% in Malawi were using contraceptives.8 Moreover, knowledge of HIV infection is not 
necessarily associated with greater use of FP. In KAIS 2007, 52% of Kenyan women who 
reported that they were infected with HIV and did not desire a child were using modern 
contraceptive methods compared with 49.4% of those who reported being HIV uninfected.3 
In Uganda, one-third of HIV-infected women reported being pregnant since their diagnosis, 
and 28% of infected men reported their sexual partner being pregnant since their own HIV 
diagnosis.7
Fertility desires are generally lower among HIV-infected women. A qualitative study among 
HIV-infected women in Nyanza showed that perceptions about side effects of contraceptive 
methods strongly influenced HIV-infected women’s choices along with access to FP and 
partners’ resistance to contraceptive use.9
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Among Kenyan women who reported they were HIV infected in KAIS 2007, 8.1% wanted a 
child within the next 2 years, and 10.5% desired a child but sometime further in the future.3 
Higher monthly income, being on antiretroviral therapy (ART), longer duration of HIV 
clinic attendance, longer period since diagnosis of HIV infection, disclosure of serostatus to 
partners, and higher CD4+ T-cell count were all associated with reduced desire for 
children.10
The second Kenya AIDS Indicator Survey (KAIS 2012) was a nationally representative 
survey conducted in 2012– 2013 among persons aged 18 months to 64 years to monitor 
progress on key indicators in the national HIV response. In this article, we examined 




The survey methods for KAIS 2012 have been described in detail elsewhere.11 Briefly, we 
selected eligible households using a stratified 2-stage cluster sampling design. Trained 
interviewers administered household and individual questionnaires. Trained laboratory 
technicians collected blood specimens for biologic testing in a central laboratory.
Study Population
Our study population consisted of sexually active women aged 15–49 years who were usual 
household residents or were present at the household residence on the night preceding the 
survey and consented to participate in the survey. Persons with cognitive or hearing 
disabilities were excluded.
Laboratory Methods
We asked women for their verbal consent to collect a blood sample for biologic testing at 
the National HIV Reference Laboratory (NHRL) in Nairobi. We tested blood specimens for 
HIV antibody and if positive, HIV RNA concentration. We tested all specimens for HIV 
antibody [Vironostika HIV-1/2 UNIF II Plus O Enzyme Immunoassay (EIA) assay; 
bioMérieux SA, Marcy l’Etoile, France] and confirmed HIV antibody-positive results with 
the Murex HIV.1.2.O HIV EIA (DiaSorin, SpA, Saluggia, Italy). Repeat testing was done 
for discordant results and if results remained discordant, final results were obtained using 
polymerase chain reaction (Cobas Amplicor HIV-1 Monitor Test, v1.5; Roche Molecular 
Diagnostics, Pleasanton, CA). We tested all HIV-positive specimens for HIV RNA 
concentration (Abbott m2000 Real-Time HIV-1 assay; Abbott Park, IL). Virologic 
suppression was defined as HIV RNA concentration <1000 copies per milliliter.
Measurements
We had 2 main outcome variables: use of FP and desire for future children. We defined 
modern contraceptives as a subset of FP methods, which included: male and female 
sterilization, oral contraceptives, intrauterine devices, injected contraceptives, implantable 
contraceptives, and male and female condoms. Rhythm/natural methods, withdrawal, 
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abstinence, and other methods were not considered to be modern contraceptive practices. 
Predictor variables included age, marital status, area of residence (urban versus rural), 
religion, socioeconomic status, educational attainment, parity, and number of living 
children. For women who were using FP, we recorded type of contraceptive used.
Women who reported previous HIV-positive diagnoses but were HIV-negative based on 
KAIS 2012 laboratory testing (N = 15) and women who reported previous HIV-negative 
diagnoses but were HIV-positive based on KAIS 2012 laboratory testing (N = 128) were 
excluded from the analysis. Hereafter, we refer to women with laboratory-diagnosed HIV-
positive test results and who self-reported HIV-positive status as women with known HIV 
infection. Women with laboratory-diagnosed HIV-negative test results and who self-
reported no HIV infection are referred to as HIV-uninfected women.
Statistical Analysis
Data were weighted to account for the survey’s sampling design and adjust for nonresponse. 
We estimated point prevalence and 95% confidence intervals (CI) for selected demographic 
and reproductive health variables. We also compared use of FP and desire for future children 
among women by HIV status. We conducted bivariate and multivariate analyses to identify 
correlates of FP and desire for future children. We report results as odds ratios (OR), 
adjusted odds ratios (aOR), and 95% CI. In the multivariate model, we included variables 
that were associated with the outcome of interest in bivariate analyses at P < 0.1. Variables 
that remained significant based on P < 0.05 were considered independently and significantly 
associated with the outcome of interest.
Ethical Considerations
The Kenya Medical Research Institute (KEMRI) Ethical Review Committee, the United 
States Centers for Disease Control and Prevention (CDC) Institutional Review Board, and 
the Committee on Human Research of the University of California, San Francisco (UCSF) 
reviewed and approved the KAIS 2012 protocol.
RESULTS
We interviewed 8035 (87.4%) of the 9189 eligible households and identified 6910 eligible 
women aged 15–49 years who lived in these households. Of these, 4394 were sexually 
active, and 3583 of these women provided information on self-reported HIV status (Table 
1). A total of 3245 completed the FP portion of the interview, and 3581 completed the 
fertility desires component. These women had a median of 1 previous live birth (IQR, 0–1) 
(data not shown). One hundred thirty-seven (4.0%, 95% CI: 3.2 to 4.7) women had known 
HIV infection, and 3446 (96.0%, 95% CI: 95.2 to 97.0) were HIV uninfected. Of the women 
whom we interviewed regarding FP, 68.2% (95% CI: 66.1 to 70.3) were using FP, and of 
those, 93.0% (95% CI: 91.8 to 94.3) were using modern contraceptive methods. Among 
women with known HIV infection, 70.8% (95% CI: 62.7 to 78.9) were using FP compared 
with 68.1% (95% CI: 65.9 to 70.3) of HIV-uninfected women. The most common FP 
methods used were injected contraceptives (47.2%) and oral contraceptives (18.6%) (data 
not shown).
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Of the women interviewed regarding their desire to have children, 57.7% (95% CI: 55.4 to 
59.9) had no desire to have children in the future, including 85.6% (95% CI: 79.9 to 91.2) of 
women with known HIV infection and 56.5% (95% CI: 54.2 to 58.9) of HIV-uninfected 
women (Table 1). Among women who did not desire future children, 70.9% (95% CI: 68.3 
to 73.5) were using contraceptives, including 68.7% (95% CI: 58.9 to 87.5) of women with 
known HIV infection and 71.0% (95% CI: 68.5 to 73.7) of HIV-uninfected women (data not 
shown).
Women with known HIV infection had similar odds of using FP as women with no HIV 
infection (OR, 1.12; 95% CI: 0.81 to 1.54) (Table 2). In multivariate analysis, being married 
or cohabiting (compared with never married or never cohabited), Roman Catholic or 
Protestant Christian (compared with other or no religion), aged 20–39 years (compared with 
aged 15–19 years), in wealth quintiles higher than the poorest, with education levels higher 
than no primary education, and having 1 child compared with no child were independently 
associated with higher adjusted odds of contraceptive use.
HIV-uninfected women had significantly higher odds of desiring future children than 
women with known HIV infection (OR, 4.07; 95% CI: 2.77 to 5.99); this difference 
persisted in multivariate analysis (adjusted odds ratio, 2.27; 95% CI: 1.31 to 3.93) (Table 3). 
In multivariate analysis, being aged 15–39 years (compared with aged 40–49 years), having 
no or 1 child (compared with having 2 or more children) and not using modern 
contraceptives were independently associated with increased odds of desiring a child in the 
future.
Among women with known HIV infection who reported FP use (N = 87), 89.2% (95% CI: 
80.8 to 97.7) were currently in HIV care. Sixty-four percent (95% CI: 53.1 to 74.6) were 
currently taking ART, and over half (55.4%, 95% CI: 43.9 to 66.9) were virally suppressed. 
Among HIV-infected women who were not using FP (N = 1049), 87.9% (95% CI: 76.1 to 
99.6) were currently in HIV care, 57.2% (95% CI: 41.3 to 73.1) were on ART, and 53.2% 
(95% CI: 36.3 to 70.1) were virally suppressed (data not shown).
DISCUSSION
In KAIS 2012, we found that approximately two-thirds of sexually active Kenyan women 
aged 15–49 years were using FP, with the majority using modern contraceptives. According 
to the Kenya 2008–2009 DHS, the percentage of women aged 15–49 years who used any 
contraceptive method was lower, at 32%.5 We also found that 6 out of 10 women did not 
want a child in the future, higher than reported in 2007, where 5 out of 10 women did not 
want a future child.3 Among these, 68.7% of women with known HIV infection and 71.0% 
of HIV-uninfected women were using FP. This was higher than reported in 2007, where, 
among women who did not desire a child in the future, only 52.0% of women who self-
reported HIV infection and 49.4% of women who self-reported being uninfected with HIV 
were using FP.3
The results of this analysis highlight progress in addressing FP needs for HIV-infected and 
HIV-uninfected women, which has coincided with the scale-up of other HIV-related 
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prevention and treatment services including routine HIV testing of pregnant women, 
provision of maternal and infant prophylaxis for HIV-infected pregnant mothers and their 
infants, and provision of ART to those in need of treatment. Still, our results highlight unmet 
FP needs, particularly for women who were aware of their HIV infection, where 
approximately 30% of women in need of FP were not receiving it. Prevention of unintended 
pregnancies constitutes an important second prong of the mother-to-child transmission 
elimination framework among HIV-infected women; yet these findings suggest that the 
prioritization of FP services may need greater emphasis in the Kenyan national PMTCT 
program. According to the reproductive health road map, Kenya intends to strengthen 
integration of FP and HIV services in all facilities by 2015 as one of the main priority 
activities for reproductive health programs.12
In our study, prevalence of FP use was similar among women with previous diagnoses of 
HIV infection and HIV-uninfected women. Adequacy of FP counseling for HIV-infected 
women has been questioned when repeat pregnancies are reported. Besides the lack of time, 
it has been reported that many women discover their HIV status during antenatal care, and 
issues, such as understanding and accepting the test result and its implications, often far 
outweigh any future FP concerns.6,7 The missed opportunities for counseling HIV-infected 
women regarding FP were well illustrated in 2 Kenya PMTCT operations research studies 
where more than one-fifth of women reported that they engaged in a discussion about FP 
during their antenatal visit, but fewer than 4% reported receiving any postpartum counseling 
on this topic.13
Efforts to increase uptake of FP need to focus on addressing barriers to access. According to 
the Kenya DHS 2008–2009, some barriers that prevent women from using FP include the 
fear of side effects and health concerns. Also, religious prohibitions, opposition to use, 
menopause, infertility, desire for many children, and infrequent sex contribute to lower use 
of FP.3 Field experiences in Kenya and Uganda on integrating FP into PMTCT have shown 
that in settings with few resources, providers simply lack the time to counsel HIV-infected 
women on FP.6,7
Our study had several limitations. All FP responses were from self-reported data, and we 
could not corroborate reported information with other data sources such as clinical or 
pharmacy records. The survey nature of KAIS 2012 precluded in-depth exploration of, for 
instance, why the respondents who did not desire having children were not using 
contraceptives. This analysis excluded women who did not report on their HIV status during 
the interview, which may have decreased the statistical power to detect associations. Finally, 
because of small sample sizes of women with known HIV infection, estimates reported on 
access to care and treatment may be unreliable and should be interpreted with caution. 
Despite these limitations, KAIS 2012 had a large sample size, was nationally representative, 
and we believe our estimates of contraceptive use and fertility desires to be generalizable.
There is need to integrate FP services, PMTCT, reproductive health care, and maternal and 
child health services in all health facilities to address the gaps of FP for both HIV-infected 
and HIV-uninfected women.14 In lowresource settings, it is likely that models of integration 
will have the largest effect by maximizing limited resources to improve outcomes. For HIV-
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infected women who do not wish to become pregnant, FP offers the added benefit of 
PMTCT and, by extension, reduces the number of children needing HIV prophylaxis, 
treatment, care, and support.15 We recommend that greater programmatic emphasis should 
be placed on FP services for all women.
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TABLE 1
Select Characteristics Among Sexually Active Women Aged 15–49 Years by HIV Status, Kenya AIDS 
Indicator Survey 2012
All (Unweighted, N = 3583)
Known HIV Infection*
(Unweighted, N = 137)
HIV-Uninfected†
(Unweighted, N = 3446)
Characteristics Unweighted, n
Weighted %
(95% CI) Unweighted, n
Weighted %
(95% CI) Unweighted, n
Weighted %
(95% CI)
Total 3583 137 3446
Marital status
 Never married/never cohabited 358 10.4 (8.9 to 
11.8)
7 4.5 (1.2 to 7.8) 351 10.6 (9.1 to 
12.1)
 Married/cohabited 2873 79.9 (78.2 to 
81.7)
93 68.7 (60.7 to 
76.6)
2780 80.4 (78.6 to 
82.2)
 Separated/divorced 186 5.2 (4.4 to 6.1) 10 6.7 (2.5 to 
10.8)
176 5.2 (4.3 to 6.0)
 Ever widowed 166 4.5 (3.7 to 5.3) 27 20.2 (13.5 to 
26.9)
139 3.8 (3.0 to 4.6)
Residence
 Rural 2204 61.8 (58.9 to 
64.7)
80 59.7 (47.9 to 
71.4)
2124 61.9 (59.0 to 
64.8)
 Urban 1379 38.2 (35.3 to 
41.1)
57 40.3 (28.6 to 
52.1)
1322 38.1 (35.2 to 
41.0)
Religion
 Roman Catholic 803 23.7 (21.2 to 
26.2)
28 20.5 (14.2 to 
26.8)
775 23.8 (21.3 to 
26.4)
 Protestant/other Christian 2402 70.0 (67.4 to 
72.7)
101 76.5 (69.0 to 
84.1)
2301 69.8 (67.0 to 
72.5)
 Other‡ 378 6.3 (4.7 to 7.8) 8 3.0 (0 to 6.7) 370 6.4 (4.8 to 8.0)
Age category, yrs
 15–19 233 6.6 (5.6 to 7.6) 2 1.9 (0 to 4.3) 231 6.8 (5.8 to 7.8)
 20–29 1695 47.3 (45.2 to 
49.4)
44 33.0 (24.4 to 
41.6)
1651 47.9 (45.7 to 
50.1)
 30–39 1124 31.3 (29.4 to 
33.1)
61 42.6 (33.3 to 
52.0)
1063 30.8 (28.9 to 
32.7)
 40–49 531 14.8 (13.5 to 
16.2)
30 22.5 (14.7 to 
30.4)
501 14.5 (13.2 to 
15.9)
Wealth index
 Poorest 655 18.1 (15.1 to 
21.0)
18 13.3 (6.5 to 
20.1)
637 18.3 (15.3 to 
21.3)
 Second 741 20.8 (18.5 to 
23.1)
34 26.1 (16.1 to 
36.2)
707 20.6 (18.3 to 
22.8)
 Middle 728 20.3 (18.1 to 
22.5)
29 24.7 (17.4 to 
32.0)
699 20.1 (17.9 to 
22.3)
 Fourth 661 18.3 (15.9 to 
20.7)
36 24.0 (15.0 to 
33.0)
625 18.1 (15.6 to 
20.5)
 Richest 798 22.5 (19.4 to 
25.6)
20 11.8 (6.1 to 
17.6)
778 23.0 (19.8 to 
26.1)
Highest educational attainment
 No primary 515 10.3 (8.7 to 
12.0)
12 5.6 (1.3 to 
10.0)
503 10.5 (8.8 to 
12.2)
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All (Unweighted, N = 3583)
Known HIV Infection*
(Unweighted, N = 137)
HIV-Uninfected†
(Unweighted, N = 3446)
Characteristics Unweighted, n
Weighted %
(95% CI) Unweighted, n
Weighted %
(95% CI) Unweighted, n
Weighted %
(95% CI)
 Incomplete primary 64 1.9 (1.3 to 2.6) 3 2.0 (0 to 4.3) 61 1.9 (1.2 to 2.6)
 Complete primary 1223 35.8 (33.6 to 
38.0)
47 36.0 (27.3 to 
44.6)
1176 35.8 (33.6 to 
38.0)
 Secondary or higher 1781 51.9 (49.6 to 
54.3)
75 56.4 (47.5 to 
65.3)
1706 51.8 (49.3 to 
54.2)
Parity
 None 995 31.0 (29.2 to 
32.8)
62 44.7 (34.3 to 
55.0)
933 30.3 (28.5 to 
32.2)
 1 1495 45.8 (43.9 to 
47.8)
38 29.7 (21.0 to 
38.4)
1457 46.5 (44.5 to 
48.5)
 ≥2 760 23.2 (21.3 to 
25.2)
33 25.6 (16.9 to 
34.3)
727 23.1 (21.2 to 
25.1)
Family planning
 Yes 2158 68.2 (66.1 to 
70.3)
87 70.8 (62.7 to 
78.9)
2071 68.1 (65.9 to 
70.3)
 No 1087 31.8 (29.7 to 
33.9)
38 29.2 (21.1 to 
37.3)
1049 31.9 (29.7 to 
34.1)
Modern contraceptive use
 Yes 1992 93.0 (91.8 to 
94.3)
85 98.4 (96.1 to 
100)
1907 92.8 (91.5 to 
94.1)
 No 166 7.0 (5.7 to 8.2) 2 1.6 (0 to 3.9) 164 7.2 (5.9 to 8.5)
Wants children in the future
 Yes 1563 42.3 (40.1 to 
44.6)
24 14.4 (8.8 to 
20.1)
1539 43.5 (41.1 to 
45.8)
 No 2018 57.7 (55.4 to 
59.9)
113 85.6 (79.9 to 
91.2)
1905 56.5 (54.2 to 
58.9)
HIV status
 Known HIV infection 137 4.0 (3.2 to 4.7) — — — —
 HIV uninfected 3446 96.0 (95.2 to 
97.0)
— — — —
*
Laboratory-confirmed HIV-positive, self-reported HIV-positive.
†
Laboratory-confirmed HIV-negative, self-reported HIV-negative.
‡
Other includes Muslim, other religions, and no religion.
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TABLE 2
Factors Associated With Use of FP Methods Among Sexually Active Women Aged 15–49 Years, Kenya 
AIDS Indicator Survey 2012
Variable Unadjusted Odds Ratio (95% CI) P Adjusted Odds Ratio (95% CI) P
HIV status
 Known HIV infection* 1.12 (0.81 to 1.54) 0.492 — —
 HIV uninfected† 1.0 — — —
Marital status
 Never married/never cohabited 1.0 — 1.0 —
 Married/cohabited 5.07 (4.30 to 5.98) <0.0001 3.90 (2.98 to 5.10) <0.0001
 Separated/divorced 1.69 (1.31 to 2.19) <0.0001 1.11 (0.79 to 1.56) 0.5625
 Ever widowed 1.65 (1.30 to 2.09) <0.0001 1.10 (0.77 to 1.58) 0.5904
Residence
 Rural 1.0 — 1.0 —
 Urban 1.32 (1.16 to 1.51) <0.0001 1.19 (0.97 to 1.46) 0.0887
Religion
 Roman Catholic 1.79 (1.37 to 2.34) <0.0001 1.98 (1.42 to 2.76) <0.0001
 Protestant/other Christian 1.84 (1.43 to 2.35) <0.0001 1.89 (1.36 to 2.62) 0.0001
 Other‡ 1.0 — 1.0 —
Age category, yrs
 15–19 1.0 — 1.0 —
 20–29 5.39 (4.42 to 6.57) <0.0001 1.79 (1.24 to 2.59) 0.0019
 30–39 6.77 (5.53 to 8.27) <0.0001 1.62 (1.09 to 2.42) 0.0183
 40–49 4.39 (3.52 to 5.48) <0.0001 0.91 (0.60 to 1.40) 0.6769
Wealth index
 Poorest 1.0 — 1.0 —
 Second 1.35 (1.12 to 1.62) 0.0013 1.55 (1.20 to 2.00) 0.0009
 Middle 1.58 (1.27 to 1.95) <0.0001 1.78 (1.34 to 2.35) <0.0001
 Fourth 1.68 (1.34 to 2.09) <0.0001 2.10 (1.54 to 2.87) <0.0001
 Richest 1.64 (1.30 to 2.06) <0.0001 2.06 (1.50 to 2.82) <0.0001
Highest educational attainment
 No primary 1.0 — 1.0 —
 Incomplete primary 2.21 (1.56 to 3.13) <0.0001 2.12 (1.26 to 3.57) 0.0045
 Complete primary 2.18 (1.80 to 2.64) <0.0001 1.80 (1.40 to 2.32) <0.0001
 Secondary or higher 2.16 (1.79 to 2.60) <0.0001 1.53 (1.21 to 1.93) 0.0003
Parity
 None 1.0 — 1.0 —
 1 1.94 (1.66 to 2.26) <0.0001 1.45 (1.21 to 1.74) <0.0001
 ≥2 1.57 (1.30 to 1.90) <0.0001 1.18 (0.95 to 1.48) 0.134
*
Laboratory-confirmed HIV-positive, self-reported HIV-positive.
†
Laboratory-confirmed HIV-negative, self-reported HIV-negative.
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‡
Other includes Muslim, other religions, and no religion.
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TABLE 3
Factors Associated With Desire for Future Children Among Sexually Active Women Aged 15–49 Years, 
Kenya AIDS Indicator Survey 2012
Variable Unadjusted Odds Ratio (95% CI) P Adjusted Odds Ratio (95% CI) P
HIV status
 Known HIV infection* 1.0 — 1.0 —
 HIV uninfected† 4.07 (2.77 to 5.99) <0.0001 2.27 (1.31 to 3.93) 0.0034
Marital status
 Never married/never cohabited 2.90 (2.46 to 3.41) <0.0001 0.97 (0.59 to 1.59) 0.8977
 Married/cohabited 1.0 — 1.0 —
 Separated/divorced 0.56 (0.44 to 0.70) <0.0001 0.65 (0.39 to 1.07) 0.0909
 Ever widowed 0.41 (0.32 to 0.53) <0.0001 0.71 (0.38 to 1.31) 0.2727
Residence
 Rural 1.0 — 1.0 —
 Urban 1.36 (1.19 to 1.56) <0.0001 1.03 (0.75 to 1.43) 0.848
Religion
 Roman Catholic 0.74 (0.59 to 0.92) 0.008 1.10 (0.60 to 2.02) 0.7519
 Protestant/other Christian 0.70 (0.57 to 0.86) 0.0006 1.05 (0.59 to 1.87) 0.8554
 Other‡ 1.0 — 1.0 —
Age category, yrs
 15–19 12.15 (9.79 to 15.08) <0.0001 85.34 (35.73 to 203.84) <0.0001
 20–29 11.71 (9.98 to 13.74) <0.0001 47.60 (22.97 to 98.64) <0.0001
 30–39 3.27 (2.71 to 3.95) <0.0001 8.13 (3.97 to 16.66) <0.0001
 40–49 1.0 — 1.0 —
Wealth index
 Poorest 1.0 — 1.0 —
 Second 0.77 (0.66 to 0.92) 0.0029 0.71 (0.50 to 1.01) 0.0534
 Middle 0.75 (0.61 to 0.91) 0.0031 0.72 (0.50 to 1.04) 0.0796
 Fourth 0.88 (0.73 to 1.07) 0.2126 0.79 (0.51 to 1.24) 0.3102
 Richest 1.29 (1.05 to 1.59) 0.0146 0.90 (0.56 to 1.44) 0.6631
Highest educational attainment
 No primary 1.0 — — —
 Incomplete primary 0.79 (0.53 to 1.19) 0.2545 — —
 Complete primary 1.05 (0.84 to 1.32) 0.6477 — —
 Secondary or higher 1.06 (0.86 to 1.32) 0.5774 — —
Parity
 None 0.56 (0.45 to 0.70) <0.0001 1.99 (1.33 to 2.97) 0.0008
 1 1.63 (1.33 to 1.99) <0.0001 2.06 (1.51 to 2.83) <0.0001
 ≥2 1.0 — — —
Modern contraceptive use
 Yes 1.0 — — —
 No 1.13 (0.93 to 1.38) 0.212 1.88 (1.20 to 2.94) 0.0056
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*
Laboratory-confirmed HIV-positive, self-reported HIV-positive.
†
Laboratory-confirmed HIV-negative, self-reported HIV-negative.
‡
Other includes Muslim, other religions, and no religion.
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